Every day, billions of people put their lives at risk simply by cooking meals. Whether open flame cooking or unsafe stoves and fuels, both methods release smoke that causes respiratory and heart disease – and lead to four million premature deaths a year.1 Access to information about smoke-related health hazards and ways to avoid them could change this outcome for the people and communities who are suffering, and for medical professionals who treat them.
In 2006, the first biosimilar – a follow-on medicine of an existing biologic – was launched in Europe. Worldwide, many more have been introduced since then. But has the past decade proven that biosimilars make a difference for patients and healthcare systems? Absolutely, says oncologist Dr. Paul Cornes in Bristol, UK. He offers six key reasons.
Get insights into the experiences of a healthcare professional in South Africa in this second episode of our series on medical professionals and their tireless efforts to increase access to healthcare. Here, Dr. Mark Sonderup, a hepatologist at an academic hospital in Cape Town, South Africa, shares his goals: to make access to medical care, and reliable medical information, as universal as he can.
By Rex Clements, Head of Global Franchises at Sandoz.
A tenth anniversary could be a fairly unremarkable date in healthcare, but 2016 marked the coming of age of biosimilars – and the next decade is full of promise for patients.
Fly over Australia’s outback, visit a midwife in Ethiopia and learn about how we can make life-changing biologic medicines accessible for more patients - in the new issue of ‘Making Access Happen - For better healthcare around the world’
This site is intended for a global audience